Información:
Error:
ID
13246
Descripción
Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML); ODM derived from: https://clinicaltrials.gov/show/NCT01422603
Link
https://clinicaltrials.gov/show/NCT01422603
Palabras clave
Versiones (1)
- 26/1/16 26/1/16 -
Titular de derechos de autor
CC BY-NC 3.0
Subido en
26 de enero de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Acute Myeloid Leukaemia NCT01422603
Eligibility Acute Myeloid Leukaemia NCT01422603
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukaemia NCT01422603
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
AML or MDS
Item
cytologically and immunophenotypically (or immunohistochemically) confirmed diagnosis of high risk aml or mds
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
C3463824 (UMLS CUI [2])
age
Item
minimum age of 18 years
boolean
C0001779 (UMLS CUI [1])
stem cell transplant
Item
eligible for allogeneic stem cell transplant by local institutional guidelines
boolean
C1504389 (UMLS CUI [1])
suitable matched-related/sibling or volunteer unrelated donor
Item
suitable matched-related/sibling or volunteer unrelated donor available, as determined by local institutional guidelines
boolean
C0013018 (UMLS CUI [1])
pregnancy
Item
negative pregnancy test for females of child-bearing potential within 7 days prior to the start of study treatment
boolean
C0032961 (UMLS CUI [1])
contraception
Item
if sexually active, male and female subjects must agree that they will use an effective method of birth control throughout the active study period
boolean
C0700589 (UMLS CUI [1])
informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
capable of and willing to comply
Item
capable of and willing to comply with scheduled visits, treatment plan and required laboratory tests
boolean
C1321605 (UMLS CUI [1])
renal and hepatic function
Item
adequate renal and hepatic function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
psychiatric, addictive or any disorder which compromises ability to give truly informed consent for participation in this study
Item
psychiatric, addictive or any disorder which compromises ability to give truly informed consent for participation in this study
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
previous allogeneic bone marrow or peripheral blood stem cell transplant
Item
previous allogeneic bone marrow or peripheral blood stem cell transplant.
boolean
C0005961 (UMLS CUI [1])
C1504389 (UMLS CUI [2])
C1504389 (UMLS CUI [2])
pregnancy or lactation
Item
pregnant or lactating women. all female subjects of child-bearing potential must have a negative pregnancy test within 7 days prior to the start of treatment.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
current active, invasive malignancy
Item
any current active, invasive malignancy excluding aml or mds
boolean
C0006826 (UMLS CUI [1])